PRS28 Cost-Effectiveness Analysis of Montelukast in 6-14-Year-Old Children With Mild-Moderate Persistent Asthma in Belarus
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2027
https://www.valueinhealthjournal.com/article/S1098-3015(12)03740-0/fulltext
Title :
PRS28 Cost-Effectiveness Analysis of Montelukast in 6-14-Year-Old Children With Mild-Moderate Persistent Asthma in Belarus
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03740-0&doi=10.1016/j.jval.2012.08.2027
First page :
A564
Section Title :
Respiratory-Related Disorders
Open access? :
No
Section Order :
1511